|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Feldman BJ and Feldman D: The development
of androgen-independent prostate cancer. Nat Rev Cancer. 1:34–45.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Debatin KM: Apoptosis pathways in cancer
and cancer therapy. Cancer Immunol Immunother. 53:153–159. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tran C, Ouk S, Clegg NJ, Chen Y, Watson
PA, Arora V, Wongvipat J, Smith-Jones PM, Yoo D, Kwon A, et al:
Development of a second-generation antiandrogen for treatment of
advanced prostate cancer. Science. 324:787–790. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Das S, Roth CP, Wasson LM and Vishwanatha
JK: Signal transducer and activator of transcription-6 (STAT6) is a
constitutively expressed survival factor in human prostate cancer.
Prostate. 67:1550–1564. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kotb S, Mosharafa A, Essawi M, Hassan H,
Meshref A and Morsy A: Circulating miRNAs 21 and 221 as biomarkers
for early diagnosis of prostate cancer. Tumour Biol.
35:12613–12617. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chang YL, Zhou PJ, Wei L, Li W, Ji Z, Fang
YX and Gao WQ: MicroRNA-7 inhibits the stemness of prostate cancer
stem-like cells and tumorigenesis by repressing KLF4/PI3K/Akt/p21
pathway. Oncotarget. 6:24017–24031. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kojima S, Enokida H, Yoshino H, Itesako T,
Chiyomaru T, Kinoshita T, Fuse M, Nishikawa R, Goto Y, Naya Y, et
al: The tumor-suppressive microRNA-143/145 cluster inhibits cell
migration and invasion by targeting GOLM1 in prostate cancer. J Hum
Genet. 59:78–87. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun Q, Zhao X, Liu X, Wang Y, Huang J,
Jiang B, Chen Q and Yu J: miR-146a functions as a tumor suppressor
in prostate cancer by targeting Rac1. Prostate. 74:1613–1621. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kobayashi N, Uemura H, Nagahama K, Okudela
K, Furuya M, Ino Y, Ito Y, Hirano H, Inayama Y, Aoki I, et al:
Identification of miR-30d as a novel prognostic maker of prostate
cancer. Oncotarget. 3:1455–1471. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Taylor BS, Schultz N, Hieronymus H,
Gopalan A, Xiao Y, Carver BS, Arora VK, Kaushik P, Cerami E, Reva
B, et al: Integrative genomic profiling of human prostate cancer.
Cancer Cell. 18:11–22. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mootha VK, Lindgren CM, Eriksson KF,
Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E,
Ridderstråle M, Laurila E, et al: PGC-1alpha-responsive genes
involved in oxidative phosphorylation are coordinately
downregulated in human diabetes. Nat Genet. 34:267–273. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu B, Niu X, Zhang X, Tao J, Wu D, Wang Z,
Li P, Zhang W, Wu H, Feng N, et al: miR-143 decreases prostate
cancer cells proliferation and migration and enhances their
sensitivity to docetaxel through suppression of KRAS. Mol Cell
Biochem. 350:207–213. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu B, Wang N, Wang X, Tong N, Shao N, Tao
J, Li P, Niu X, Feng N, Zhang L, et al: MiR-146a suppresses tumor
growth and progression by targeting EGFR pathway and in a
p-ERK-dependent manner in castration-resistant prostate cancer.
Prostate. 72:1171–1178. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Garcia DM, Baek D, Shin C, Bell GW,
Grimson A and Bartel DP: Weak seed-pairing stability and high
target-site abundance decrease the proficiency of lsy-6 and other
microRNAs. Nat Struct Mol Biol. 18:1139–1146. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Krüger J and Rehmsmeier M: RNAhybrid:
microRNA target prediction easy, fast and flexible. Nucleic Acids
Res. 34:(Web Server Issue). W451–W454. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rahal OM, Wolfe AR, Mandal PK, Larson R,
Tin S, Jimenez C, Zhang D, Horton J, Reuben JM, McMurray JS and
Woodward WA: Blocking interleukin (IL)4- and IL13-mediated
phosphorylation of STAT6 (Tyr641) decreases M2 polarization of
macrophages and protects against macrophage-mediated
radioresistance of inflammatory breast cancer. Int J Radiat Oncol
Biol Phys. 100:1034–1043. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sun T, Wang X, He HH, Sweeney CJ, Liu SX,
Brown M, Balk S, Lee GS and Kantoff PW: MiR-221 promotes the
development of androgen independence in prostate cancer cells via
downregulation of HECTD2 and RAB1A. Oncogene. 33:2790–2800. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou W, Li X, Liu F, Xiao Z, He M, Shen S
and Liu S: MiR-135a promotes growth and invasion of colorectal
cancer via metastasis suppressor 1 in vitro. Acta Biochim Biophys
Sin (Shanghai). 44:838–846. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen Y, Zhang J, Wang H, Zhao J, Xu C, Du
Y, Luo X, Zheng F, Liu R, Zhang H and Ma D: miRNA-135a promotes
breast cancer cell migration and invasion by targeting HOXA10. BMC
Cancer. 12:1112012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yamada Y, Hidaka H, Seki N, Yoshino H,
Yamasaki T, Itesako T, Nakagawa M and Enokida H: Tumor-suppressive
microRNA-135a inhibits cancer cell proliferation by targeting the
c-MYC oncogene in renal cell carcinoma. Cancer Sci. 104:304–312.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu H, Huang M, Cao P, Wang T, Shu Y and
Liu P: MiR-135a targets JAK2 and inhibits gastric cancer cell
proliferation. Cancer Biol Ther. 13:281–288. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou L, Qiu T, Xu J, Wang T, Wang J, Zhou
X, Huang Z, Zhu W, Shu Y and Liu P: miR-135a/b modulate cisplatin
resistance of human lung cancer cell line by targeting MCL1. Pathol
Oncol Res. 19:677–683. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Holleman A, Chung I, Olsen RR, Kwak B,
Mizokami A, Saijo N, Parissenti A, Duan Z, Voest EE and Zetter BR:
miR-135a contributes to paclitaxel resistance in tumor cells both
in vitro and in vivo. Oncogene. 30:4386–4398. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Watson CJ: Stat transcription factors in
mammary gland development and tumorigenesis. J Mammary Gland Biol
Neoplasia. 6:115–127. 2001. View Article : Google Scholar : PubMed/NCBI
|
